Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-29

Clinical Trial Update: Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes

View source ↗

Summary

A completed observational study evaluating the safety of Levemir (insulin detemir) in patients with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED